Previous study published that hyperimmune sera obtained in non-small cell lung cancer patients treated with an EGF-based vaccine was able to inhibit the HER1 phosphorylation trough the anti-EGF specific antibodies. Here, EGFR is linked to non-small cell lung carcinoma.